1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MYO1E CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA PLP1 CTRPv2 pan-cancer AAC 0.2 3e-05
mRNA FXYD3 CTRPv2 pan-cancer AAC 0.18 3e-05
mRNA SERPINB4 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA WDR62 CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA SNRPB2 CTRPv2 pan-cancer AAC 0.17 3e-05
mRNA HHAT CTRPv2 pan-cancer AAC 0.17 3e-05
mRNA CH17-270A2.2 CTRPv2 pan-cancer AAC -0.17 3e-05
mRNA ACSS2 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA MELTF CTRPv2 pan-cancer AAC 0.17 3e-05
Download CSV